# Rivaroxaban Post Coronary Bypass Surgery

> **NCT06019741** · PHASE4 · COMPLETED · sponsor: **Shiraz University of Medical Sciences** · enrollment: 234 (actual)

## Conditions studied

- Post Coronary Bypass Surgery Patients

## Interventions

- **DRUG:** Rivaroxaban and aspirin 80
- **DRUG:** Aspirin 80

## Key facts

- **NCT ID:** NCT06019741
- **Lead sponsor:** Shiraz University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-01
- **Primary completion:** 2022-05-01
- **Final completion:** 2022-07-20
- **Target enrollment:** 234 (ACTUAL)
- **Last updated:** 2023-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06019741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06019741, "Rivaroxaban Post Coronary Bypass Surgery". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT06019741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*